Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
GlaxoSmithKline
Scientific Title
A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers